Kristen Gajewski - Feb 1, 2023 Form 3 Insider Report for AVIENT CORP (AVNT)

Role: SVP & CHRO
Signature: /s/ Lisa K. Kunkle, Power of Attorney For: Kristen Gajewski
Stock symbol: AVNT
Transactions as of: Feb 1, 2023
Transactions value $: $0
Form type: 3
Date filed: 2/8/2023, 09:45 AM
Next filing: Feb 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AVNT	Common Stock						929	Feb 1, 2023	Direct
holding	AVNT	Common Stock						840	Feb 1, 2023	Savings Plan Trust	F1
holding	AVNT	Common Stock						95.2	Feb 1, 2023	Supplemental Plan	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AVNT	Restricted Stock Units							Feb 1, 2023	Common Stock	769		Direct	F2, F3
holding	AVNT	Restricted Stock Units							Feb 1, 2023	Common Stock	670		Direct	F3, F4
holding	AVNT	Restricted Stock Units							Feb 1, 2023	Common Stock	668		Direct	F3, F5
holding	AVNT	Stock Appreciation Rights							Feb 1, 2023	Common Stock	1.15K	$41.89	Direct	F6
holding	AVNT	Stock Appreciation Rights							Feb 1, 2023	Common Stock	700	$31.54	Direct	F7
holding	AVNT	Stock Appreciation Rights							Feb 1, 2023	Common Stock	1.47K	$31.48	Direct	F8
holding	AVNT	Stock Appreciation Rights							Feb 1, 2023	Common Stock	2.57K	$42.27	Direct	F9
holding	AVNT	Stock Appreciation Rights							Feb 1, 2023	Common Stock	2.3K	$52.64	Direct	F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The information in this report is based on a plan statement as of February 1, 2023.
F2	The restricted stock units vest 3 years from the date of grant on February 10, 2023.
F3	The restricted stock units include all dividend equivalents acquired since the date of grant. Dividend equivalents are subject to the same restrictions as the underlying grant of restricted stock units.
F4	The restricted stock units vest 3 years from the date of grant on February 8, 2024.
F5	The restricted stock units vest 3 years from the date of grant on February 14, 2025.
F6	SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.
F7	SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.
F8	SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.
F9	SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years.
F10	SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.